Expression profiling of the mouse prostate after castration and hormone replacement: Implication of H-cadherin in prostate tumorigenesis

Differentiation

Volumn 75, Issue 3, 2007, Pages 219-234

  Wang, Xi De ^a,c   Wang, Bu Er ^a   Soriano, Robert ^a   Zha, Jiping ^a   Zhang, Zemin ^a   Modrusan, Zora ^a   Cunha, Gerald R ^b   Gao, Wei Qiang ^a  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Androgen responsive program; Castration; H cadherin; Mouse model; Prostate cancer; Prostate re growth

Indexed keywords

ANDROGEN; CADHERIN; H CADHERIN; PROBASIN; SOMATOMEDIN BINDING PROTEIN 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX3.1; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CASTRATION; CELL ADHESION; CELL CYCLE PROGRESSION; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE REPRESSION; HORMONE SUBSTITUTION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGANOGENESIS; PRIORITY JOURNAL; PROSTATE DEVELOPMENT; PROSTATE TUMOR; PROTEIN METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALIA; MUS;

EID: 33947233837     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1111/j.1432-0436.2006.00135.x     Document Type: Article

References (56)

1. Abate-Shen, C. and Shen, M.M. (2000) Molecular genetics of prostate cancer. Genes Dev 14:2410-2434.
2. Amler, L.C., Agus, D.B., LeDuc, C., Sapinoso, M.L., Fox, W.D., Kern, S., Lee, D., Wang, V., Leysens, M., Higgins, B., Martin, J., Gerald, W., Dracopoli, N., Cordon-Cardo, C., Scher, H.I. and Hampton, G.M. (2000) Dysregulated expression of androgenresponsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res 60:6134-6141.
3. Arnold, J.T., Le, H., McFann, K.K. and Blackman, M.R. (2005) Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Am J Physiol Endocrinol Metab 288:E573-E584.
4. Bieberich, C.J., Fujita, K., He, W.W. and Jay, G. (1996) Prostate-specific and androgen-dependent expression of a novel homeobox gene. J Biol Chem 271:31779-31782.
5. Chatterjee, B. (2003) The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer. Mol Cell Biochem 253:89-101.
6. Corey, E., Quinn, J.E., Buhler, K.R., Nelson, P.S., Macoska, J.A., True, L.D. and Vessella, R.L. (2003) LuCaP 35: a new model of prostate cancer progression to androgen independence. Prostate 55:239-246.
7. Cunha, G.R., Donjacour, A.A., Cooke, P.S., Mee, S., Bigsby, R.M., Higgins, S.J. and Sugimura, Y. (1987) The endocrinology and developmental biology of the prostate. Endocrinol Rev 8:338-362.
8. Denmeade, S.R. and Isaacs, J.T. (2002) A history of prostate cancer treatment. Nat Rev Cancer 2:389-396.
9. Dennis, G. Jr., Sherman, B.T., Hosack, D.A., Yang, J., Gao, W., Lane, H.C. and Lempicki, R.A. (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3.
10. DePrimo, S.E., Diehn, M., Nelson, J.B., Reiter, R.E., Matese, J., Fero, M., Tibshirani, R., Brown, P.O. and Brooks, J.D. (2002) Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 3: RESEARCH0032.
11. Desai, K.V., Michalowska, A.M., Kondaiah, P., Ward, J.M., Shih, J.H. and Green, J.E. (2004) Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate. Mol Endocrinol 18:2895-2907.
12. Dhanasekaran, S.M., Dash, A., Yu, J., Maine, I.P., Laxman, B., Tomlins, S.A., Creighton, C.J., Menon, A., Rubin, M.A. and Chinnaiyan, A.M. (2005) Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty. Faseb J 19:243-245.
13. Hayward, S.W., Dahiya, R., Cunha, G.R., Bartek, J., Deshpande, N. and Narayan, P. (1995) Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim 31: 14-24.
14. Hayward, S.W., Wang, Y., Cao, M., Hom, Y.K., Zhang, B., Grossfeld, G.D., Sudilovsky, D. and Cunha, G.R. (2001) Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 61:8135-8142.
15. Heinlein, C.A. and Chang, C. (2002) Androgen receptor (AR) coregulators: an overview. Endocrinol Rev 23:175-200.
16. Hibi, K., Kodera, Y., Ito, K., Akiyama, S. and Nakao, A. (2004) Methylation pattern of CDH13 gene in digestive tract cancers. Br J Cancer 91:1139-1142.
17. Hong, J., Zhang, G., Dong, F. and Rechler, M.M. (2002) Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem 277:10489-10497.
18. Huang, H., Reed, C.P., Zhang, J.S., Shridhar, V., Wang, L. and Smith, D.I. (1999) Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells. Cancer Res 59:2981-2988.
19. Huang, Z.Y., Wu, Y., Hedrick, N. and Gutmann, D.H. (2003) Tcadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression. Mol Cell Biol 23:566-578.
20. Isaacs, J.T. (1985) Control of cell proliferation and death in the normal and neoplastic prostate: a stem cell model. In: Rogers, C.H., Coffey, D.S., Cunha, G.R., Grayhack, J.T., Hinman, F. Jr and Horton, R. eds. Benign prostatic hyperplasia. National Institutes of Health, Bethesda, pp. 85-94.
21. Isaacs, J.T., Furuya, Y. and Berges, R. (1994) The role of androgen in the regulation of programmed cell death/apoptosis in normal and malignant prostatic tissue. Semin Cancer Biol 5:391-400.
22. Jiang, F. and Wang, Z. (2003) Identification of androgen-responsive genes in the rat ventral prostate by complementary deoxyribonucleic acid subtraction and microarray. Endocrinology 144:1257-1265.
23. Jin, H., Yang, R., Awad, T.A., Wang, F., Li, W., Williams, S.P., Ogasawara, A., Shimada, B., Williams, P.M., de Feo, G. and Paoni, N.F. (2001) Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation 103:736-742.
24. Johnson, M.A., Hernandez, I., Wei, Y. and Greenberg, N. (2000) Isolation and characterization of mouse probasin: an androgen-regulated protein specifically expressed in the differentiated prostate. Prostate 43:255-262.
25. Kawakami, M., Staub, J., Cliby, W., Hartmann, L., Smith, D.I. and Shridhar, V. (1999) Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer. Int J Oncol 15:715-720.
26. Kwong, J., Xuan, J.W., Chan, P.S., Ho, S.M. and Chan, F.L. (2000) A comparative study of hormonal regulation of three secretory proteins (prostatic secretory protein-PSP94, probasin, and seminal vesicle secretion II) in rat lateral prostate. Endocrinology 141:4543-4551.
27. Kyprianou, N., Bruckheimer, E.M. and Guo, Y. (2000) Cell proliferation and apoptosis in prostate cancer: significance in disease progression and therapy. Histol Histopathol 15:1211-1223.
28. Lee, C. (1981) Physiology of castration-induced regression in rat prostate. In: Karr, J.P., Sandberg, A.A. and Murphy, G.P. eds. The prostatic cell: Structure and function, Part A. AR Liss, New York, pp. 145-159.
29. Lee, S.W. (1996) H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med 2:776-782.
30. Lee, W.H., Morton, R.A., Epstein, J.I., Brooks, J.D., Campbell, P.A., Bova, G.S., Hsieh, W.S., Isaacs, W.B. and Nelson, W.G. (1994) Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 91:11733-11737.
31. Lodygin, D., Epanchintsev, A., Menssen, A., Diebold, J. and Hermeking, H. (2005) Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 65:4218-4227.
32. Marker, P.C., Donjacour, A.A., Dahiya, R. and Cunha, G.R. (2003) Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253:165-174.
33. Maruyama, R., Toyooka, S., Toyooka, K.O., Virmani, A.K., Zochbauer-Muller, S., Farinas, A.J., Minna, J.D., McConnell, J., Frenkel, E.P. and Gazdar, A.F. (2002) Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 8:514-519.
34. McPherson, S.J., Thomas, T.Z., Wang, H., Gurusinghe, C.J. and Risbridger, G.P. (1997) Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145. J Endocrinol 154:535-545.
35. Melkonyan, H.S., Chang, W.C., Shapiro, J.P., Mahadevappa, M., Fitzpatrick, P.A., Kiefer, M.C., Tomei, L.D. and Umansky, S.R. (1997) SARPs: a family of secreted apoptosis-related proteins. Proc Natl Acad Sci USA 94:13636-13641.
36. Mills, J.S., Needham, M. and Parker, M.G. (1987a) Androgen regulated expression of a spermine binding protein gene in mouse ventral prostate. Nucleic Acids Res 15:7709-7724.
37. Mills, J.S., Needham, M. and Parker, M.G. (1987b) A secretory protease inhibitor requires androgens for its expression in male sex accessory tissues but is expressed constitutively in pancreas. Embo J 6:3711-3717.
38. Mukoyama, Y., Zhou, S., Miyachi, Y. and Matsuyoshi, N. (2005) T-cadherin negatively regulates the proliferation of cutaneous squamous carcinoma cells. J Invest Dermatol 124:833-838.
39. Nantermet, P.V., Xu, J., Yu, Y., Hodor, P., Holder, D., Adamski, S., Gentile, M.A., Kimmel, D.B., Harada, S., Gerhold, D., Freedman, L.P. and Ray, W.J. (2004) Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland. J Biol Chem 279:1310-1322.
40. Nelson, P.S., Clegg, N., Arnold, H., Ferguson, C., Bonham, M., White, J., Hood, L. and Lin, B. (2002) The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci USA 99:11890-11895.
41. Nickerson, T., Pollak, M. and Huynh, H. (1998) Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4 and 5. Endocrinology 139:807-810.
42. Ogama, Y., Ouchida, M., Yoshino, T., Ito, S., Takimoto, H., Shiote, Y., Ishimaru, F., Harada, M., Tanimoto, M. and Shimizu, K. (2004) Prevalent hyper-methylation of the CDH13 gene promoter in malignant B cell lymphomas. Int J Oncol 25:685-691.
43. Okegawa, T., Li, Y., Pong, R.C., Bergelson, J.M., Zhou, J. and Hsieh, J.T. (2000) The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res 60:5031-5036.
44. Pang, S.T., Dillner, K., Wu, X., Pousette, A., Norstedt, G. and Flores-Morales, A. (2002) Gene expression profiling of androgen deficiency predicts a pathway of prostate apoptosis that involves genes related to oxidative stress. Endocrinology 143:4897-4906.
45. Pettaway, C.A., Pathak, S., Greene, G., Ramirez, E., Wilson, M.R., Killion, J.J. and Fidler, I.J. (1996) Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 2:1627-1636.
46. Pong, R.C., Lai, Y.J., Chen, H., Okegawa, T., Frenkel, E., Sagalowsky, A. and Hsieh, J.T. (2003) Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells. Cancer Res 63:8680-8686.
47. Rajah, R., Valentinis, B. and Cohen, P. (1997) Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 272:12181-12188.
48. Ranscht, B. and Dours-Zimmermann, M.T. (1991) T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron 7:391-402.
49. Rauen, K.A., Sudilovsky, D., Le, J.L., Chew, K.L., Hann, B., Weinberg, V., Schmitt, L.D. and McCormick, F. (2002) Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res 62:3812-3818.
50. Roman-Gomez, J., Castillejo, J.A., Jimenez, A., Cervantes, F., Boque, C., Hermosin, L., Leon, A., Granena, A., Colomer, D., Heiniger, A. and Torres, A. (2003) Cadherin-13, a mediator of calcium-dependent cell - cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa. J Clin Oncol 21:1472-1479.
51. Ruan, W., Powell-Braxton, L., Kopchick, J.J. and Kleinberg, D.L. (1999) Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development. Endocrinology 140:1984-1989.
52. Sakai, M., Hibi, K., Koshikawa, K., Inoue, S., Takeda, S., Kaneko, T. and Nakao, A. (2004) Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer. Cancer Sci 95:588-591.
53. Sato, M., Mori, Y., Sakurada, A., Fujimura, S. and Horii, A. (1998) The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Genet 103:96-101.
54. Schmitt, J.F., Millar, D.S., Pedersen, J.S., Clark, S.L., Venter, D.J., Frydenberg, M., Molloy, P.L. and Risbridger, G.P. (2002) Hypermethylation of the inhibin alpha-subunit gene in prostate carcinoma. Mol Endocrinol 16:213-220.
55. Shappell, S.B., Thomas, G.V., Roberts, R.L., Herbert, R., Ittmann, M.M., Rubin, M.A., Humphrey, P.A., Sundberg, J.P., Rozengurt, N., Barrios, R., Ward, J.M. and Cardiff, R.D. (2004) Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the mouse models of human cancer consortium prostate pathology committee. Cancer Res 64:2270-2305.
56. Simon, A.M., Veyssiere, G. and Jean, C. (1995) Structure and sequence of a mouse gene encoding an androgen-regulated protein: a new member of the seminal vesicle secretory protein family. J Mol Endocrinol 15:305-316.